Research graph
References from Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL ‐2 Inhibitors. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1007/s00277‐024‐05854‐1
10.1007/s00277‐024‐05854‐1 · External reference
10.1016/j.leukres.2013.08.009
10.1016/j.leukres.2013.08.009 · External reference
10.1182/blood‐2017‐09‐806398
10.1182/blood‐2017‐09‐806398 · External reference
10.1002/ajh.27546
10.1002/ajh.27546 · External reference
10.1038/leu.2010.208
10.1038/leu.2010.208 · External reference
10.1038/nrc2764
10.1038/nrc2764 · External reference
10.1182/asheducation‐2017.1.329
10.1182/asheducation‐2017.1.329 · External reference
10.3324/haematol.2021.278304
10.3324/haematol.2021.278304 · External reference
10.1182/blood‐2018‐08‐870238
10.1182/blood‐2018‐08‐870238 · External reference
10.1200/jco.21.01210
10.1200/jco.21.01210 · External reference
10.1056/nejmoa2211582
10.1056/nejmoa2211582 · External reference
10.1056/nejmoa2515458
10.1056/nejmoa2515458 · External reference
10.1200/jco‐25‐00166
10.1200/jco‐25‐00166 · External reference
10.1182/blood.2021015014
10.1182/blood.2021015014 · External reference
10.1002/ajh.27563
10.1002/ajh.27563 · External reference
